Accelerating AI Governance Maturity From Principles into Practice | Spotlight: Madrigal Pharmaceuticals

Hosted by Credo AI

In a special segment, learn from Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, their vision for AI-native pharma in 2030, ranging from third party AI vetting to autonomous decision-making. Learn how they're working with Credo AI to future-proof governance for LLMs, multi-agent systems, and generative AI in regulated environments.

When

Watch any time · recorded 8 Sep

Format

On demand

Speakers

Parth Patel (Executive Director, Director of AI and Data Science), Jeff Sizemore (Head of Advisory Services)